24-Week β-alanine ingestion does not affect muscle taurine or clinical blood parameters in healthy males

  • Bryan SaundersEmail author
  • Mariana Franchi
  • Luana Farias de Oliveira
  • Vinicius da Eira Silva
  • Rafael Pires da Silva
  • Vitor de Salles Painelli
  • Luiz Augusto Riani Costa
  • Craig Sale
  • Roger Charles Harris
  • Hamilton Roschel
  • Guilherme Giannini Artioli
  • Bruno Gualano
Original Contribution



To investigate the effects of chronic beta-alanine (BA) supplementation on muscle taurine content, blood clinical markers and sensory side-effects.


Twenty-five healthy male participants (age 27 ± 4 years, height 1.75 ± 0.09 m, body mass 78.9 ± 11.7 kg) were supplemented with 6.4 g day−1 of sustained-release BA (N = 16; CarnoSyn™, NAI, USA) or placebo (PL; N = 9; maltodextrin) for 24 weeks. Resting muscle biopsies of the m. vastus lateralis were taken at 0, 12 and 24 weeks and analysed for taurine content (BA, N = 12; PL, N = 6) using high-performance liquid chromatography. Resting venous blood samples were taken every 4 weeks and analysed for markers of renal, hepatic and muscle function (BA, N = 15; PL, N = 8; aspartate transaminase; alanine aminotransferase; alkaline phosphatase; lactate dehydrogenase; albumin; globulin; creatinine; estimated glomerular filtration rate and creatine kinase).


There was a significant main effect of group (p = 0.04) on muscle taurine, with overall lower values in PL, although there was no main effect of time or interaction effect (both p > 0.05) and no differences between specific timepoints (week 0, BA: 33.67 ± 8.18 mmol kg−1 dm, PL: 27.75 ± 4.86 mmol kg−1 dm; week 12, BA: 35.93 ± 8.79 mmol kg−1 dm, PL: 27.67 ± 4.75 mmol kg−1 dm; week 24, BA: 35.42 ± 6.16 mmol kg−1 dm, PL: 31.99 ± 5.60 mmol kg−1 dm). There was no effect of treatment, time or any interaction effects on any blood marker (all p > 0.05) and no self-reported side-effects in these participants throughout the study.


The current study showed that 24 weeks of BA supplementation at 6.4 g day−1 did not significantly affect muscle taurine content, clinical markers of renal, hepatic and muscle function, nor did it result in chronic sensory side-effects, in healthy individuals. Since athletes are likely to engage in chronic supplementation, these data provide important evidence to suggest that supplementation with BA at these doses for up to 24 weeks is safe for healthy individuals.


Chronic beta-alanine supplementation Muscle taurine Clinical markers Safety Side-effects 



The authors would like to thank National Alternatives International, San Marcos, California for providing the β-alanine (Carnosyn™) and maltodextrin supplements. Gratitude is extended to the participants who took part in the study for their time and dedication. We would also like to extend our thanks to Dr Miriam Sanz Roldán and Dr Felipe Augusto Dörr for their essential help with the HPLC method.

Author contributions

BS, CS, RCH, HR, GGA and BG designed the research question. BS, MF, LFO, VES, RPS, VSP and LARC conducted the research. HR, GGA and BG provided essential reagents, or provided essential materials. BS, MF, LFO, VES, RPS, VSP and LARC analysed the data or performed statistical analysis. BS, CS, RCH, HR, GGA and BG wrote the manuscript. BS had primary responsibility for final content. All authors have read and approved the final manuscript.


Bryan Saunders (2016/50438-0 and 2017/04973-4), Mariana Franchi (2015/22686-7), Vitor de Salles Painelli (2013/04806-0), Rafael Pires da Silva (2012/13026-5), Guilherme Giannini Artioli (2014/11948-8) and Bruno Gualano (2013/14746-4) have been financially supported by Fundação de Amparo à Pesquisa do Estado de Sao Paulo. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES)—Finance Code 001. Bryan Saunders has previously received a scholarship Grant from National Alternatives International (NAI), San Marcos, California. Prior to his retirement from academia in 2009, Professor Roger Harris held research Grants for beta-alanine research in equines and humans from UK national funding bodies, as well as from NAI, in this case jointly with colleagues at the Korea National Sport University. Today, Professor Harris is a named inventor, along with other colleagues from these early studies, on patents owned by NAI describing methods to increase carnosine levels in muscle using beta-alanine supplements. Professor Harris provides services as an unpaid director to Junipa Ltd, a company supporting research and sponsoring conferences and for several years acted as an independent consultant to NAI and Nottingham Trent University (UK) in relation to beta-alanine research.


  1. 1.
    Hill CA, Harris RC, Kim HJ, Harris BD, Sale C, Boobis LH, Kim CK, Wise JA (2007) Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids 32(2):225–233. CrossRefPubMedGoogle Scholar
  2. 2.
    Harris RC, Tallon MJ, Dunnett M, Boobis L, Coakley J, Kim HJ, Fallowfield JL, Hill CA, Sale C, Wise JA (2006) The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids 30(3):279–289. CrossRefPubMedGoogle Scholar
  3. 3.
    Saunders B, de Salles Painelli V, De Oliveira LF, da Eira Silva V, Da Silva RP, Riani L, Franchi M, de Souza Gonçalves L, Harris RC, Roschel H, Artioli GG, Sale C, Gualano B (2017) Twenty-four weeks of beta-alanine supplementation on carnosine content, related genes, and exercise. Med Sci Sports Exerc 49(5):896–906. CrossRefPubMedGoogle Scholar
  4. 4.
    Hobson RM, Saunders B, Ball G, Harris R, Sale C (2012) Effects of beta-alanine supplementation on exercise performance: a meta-analysis. Med Sci Sport Exer 44:446–446Google Scholar
  5. 5.
    Saunders B, Elliott-Sale K, Artioli GG, Swinton PA, Dolan E, Roschel H, Sale C, Gualano B (2017) Beta-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med 51(8):658–669. CrossRefPubMedGoogle Scholar
  6. 6.
    Kelly VG, Leveritt MD, Brennan CT, Slater GJ, Jenkins DG (2017) Prevalence, knowledge and attitudes relating to beta-alanine use among professional footballers. J Sci Med Sport 20(1):12–16. CrossRefPubMedGoogle Scholar
  7. 7.
    Ripps H, Shen W (2012) Review: taurine: a “very essential” amino acid. Mol Vis 18(274–277):2673–2686PubMedPubMedCentralGoogle Scholar
  8. 8.
    Schaffer SW, Jong CJ, Ramila KC, Azuma J (2010) Physiological roles of taurine in heart and muscle. J Biomed Sci 17(Suppl 1):S2. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Everaert I, De Naeyer H, Taes Y, Derave W (2013) Gene expression of carnosine-related enzymes and transporters in skeletal muscle. Eur J Appl Physiol 113(5):1169–1179. CrossRefPubMedGoogle Scholar
  10. 10.
    Bakardjiev A, Bauer K (1994) Transport of beta-alanine and biosynthesis of carnosine by skeletal muscle cells in primary culture. Eur J Biochem 225(2):617–623CrossRefGoogle Scholar
  11. 11.
    Dawson R Jr, Biasetti M, Messina S, Dominy J (2002) The cytoprotective role of taurine in exercise-induced muscle injury. Amino Acids 22(4):309–324. CrossRefPubMedGoogle Scholar
  12. 12.
    Ito T, Yoshikawa N, Inui T, Miyazaki N, Schaffer SW, Azuma J (2014) Tissue depletion of taurine accelerates skeletal muscle senescence and leads to early death in mice. PLoS One 9(9):e107409. CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Harris RC, Kim HJ, Kim CK, Kendrick IP, Price KA, Wise JA (2010) Simultaneous changes in muscle carnosine and taurine during and following supplementation with b-alanine. Med Sci Sport Exerc 42(5):107–107CrossRefGoogle Scholar
  14. 14.
    Blancquaert L, Baba SP, Kwiatkowski S, Stautemas J, Stegen S, Barbaresi S, Chung WL, Boakye AA, Hoetker JD, Bhatnagar A, Delanghe J, Vanheel B, Veiga-da-Cunha M, Derave W, Everaert I (2016) Carnosine and anserine homeostasis in skeletal muscle and heart is controlled by beta-alanine transamination. J Physiol Lond 594(17):4849–4863. CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Stellingwerff T, Anwander H, Egger A, Buehler T, Kreis R, Decombaz J, Boesch C (2012) Effect of two beta-alanine dosing protocols on muscle carnosine synthesis and washout. Amino Acids 42(6):2461–2472. CrossRefPubMedGoogle Scholar
  16. 16.
    del Favero S, Roschel H, Solis MY, Hayashi AP, Artioli GG, Otaduy MC, Benatti FB, Harris RC, Wise JA, Leite CC, Pereira RM, de Sa-Pinto AL, Lancha AH, Gualano B (2012) Beta-alanine (Carnosyn (TM)) supplementation in elderly subjects (60–80 years): effects on muscle carnosine content and physical capacity. Amino Acids 43(1):49–56. CrossRefPubMedGoogle Scholar
  17. 17.
    Maughan RJ, Burke LM, Dvorak J, Larson-Meyer DE, Peeling P, Phillips SM, Rawson ES, Walsh NP, Garthe I, Geyer H, Meeusen R, van Loon LJC, Shirreffs SM, Spriet LL, Stuart M, Vernec A, Currell K, Ali VM, Budgett RG, Ljungqvist A, Mountjoy M, Pitsiladis YP, Soligard T, Erdener U, Engebretsen L (2018) IOC consensus statement: dietary supplements and the high-performance athlete. Br J Sports Med 52(7):439–455. CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Crozier RA, Ajit SK, Kaftan EJ, Pausch MH (2007) MrgD activation inhibits KCNQ/M-currents and contributes to enhanced neuronal excitability. J Neurosci Off J Soc Neurosci 27(16):4492–4496. CrossRefGoogle Scholar
  19. 19.
    Decombaz J, Beaumont M, Vuichoud J, Bouisset F, Stellingwerff T (2012) Effect of slow-release beta-alanine tablets on absorption kinetics and paresthesia. Amino Acids 43(1):67–76. CrossRefPubMedGoogle Scholar
  20. 20.
    Saunders B, Sale C, Harris RC, Morris JG, Sunderland C (2013) Reliability of a high-intensity cycling capacity test. J Sci Med Sport 16(3):286–289. CrossRefPubMedGoogle Scholar
  21. 21.
    Bergstrom J (1975) Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Investig 35(7):609–616CrossRefGoogle Scholar
  22. 22.
    Neves M Jr, Barreto G, Boobis L, Harris R, Roschel H, Tricoli V, Ugrinowitsch C, Negrao C, Gualano B (2012) Incidence of adverse events associated with percutaneous muscular biopsy among healthy and diseased subjects. Scand J Med Sci Sports 22(2):175–178. CrossRefPubMedGoogle Scholar
  23. 23.
    Dunnett M, Harris RC (1997) High-performance liquid chromatographic determination of imidazole dipeptides, histidine, 1-methylhistidine and 3-methylhistidine in equine and camel muscle and individual muscle fibres. J Chromatogr B Biomed Sci Appl 688(1):47–55CrossRefGoogle Scholar
  24. 24.
    Dunnett M, Harris RC, Soliman MZ, Suwar AA (1997) Carnosine, anserine and taurine contents in individual fibres from the middle gluteal muscle of the camel. Res Vet Sci 62(3):213–216CrossRefGoogle Scholar
  25. 25.
    Everaert I, Stegen S, Vanheel B, Taes Y, Derave W (2013) Effect of beta-alanine and carnosine supplementation on muscle contractility in mice. Med Sci Sports Exerc 45(1):43–51. CrossRefPubMedGoogle Scholar
  26. 26.
    Warskulat U, Flogel U, Jacoby C, Hartwig HG, Thewissen M, Merx MW, Molojavyi A, Heller-Stilb B, Schrader J, Haussinger D (2004) Taurine transporter knockout depletes muscle taurine levels and results in severe skeletal muscle impairment but leaves cardiac function uncompromised. FASEB J 18(3):577–579. CrossRefPubMedGoogle Scholar
  27. 27.
    Hamilton EJ, Berg HM, Easton CJ, Bakker AJ (2006) The effect of taurine depletion on the contractile properties and fatigue in fast-twitch skeletal muscle of the mouse. Amino Acids 31(3):273–278. CrossRefPubMedGoogle Scholar
  28. 28.
    Galloway SD, Talanian JL, Shoveller AK, Heigenhauser GJ, Spriet LL (2008) Seven days of oral taurine supplementation does not increase muscle taurine content or alter substrate metabolism during prolonged exercise in humans. J Appl Physiol (1985) 105(2):643–651. CrossRefGoogle Scholar
  29. 29.
    Tallon MJ, Harris RC, Maffulli N, Tarnopolsky MA (2007) Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects. Biogerontology 8(2):129–137. CrossRefPubMedGoogle Scholar
  30. 30.
    Blancquaert L, Everaert I, Missinne M, Baguet A, Stegen S, Volkaert A, Petrovic M, Vervaet C, Achten E, De Maeyer M, De Henauw S (2017) Effects of histidine and beta-alanine supplementation on human muscle carnosine storage. Med Sci Sports Exerc 49(3):602–609. CrossRefPubMedGoogle Scholar
  31. 31.
    Harris RC, Dunnett M, Greenhaff PL (1998) Carnosine and taurine contents in individual fibres of human vastus lateralis muscle. J Sport Sci 16(7):639–643CrossRefGoogle Scholar
  32. 32.
    Church DD, Hoffman JR, Varanoske AN, Wang R, Baker KM, La Monica MB, Beyer KS, Dodd SJ, Oliveira LP, Harris RC, Fukuda DH, Stout JR (2017) Comparison of two beta-alanine dosing protocols on muscle carnosine elevations. J Am Coll Nutr. CrossRefPubMedGoogle Scholar
  33. 33.
    Varanoske AN, Hoffman JR, Church DD, Coker NA, Baker KM, Dodd SJ, Oliveira LP, Dawson VL, Wang R, Fukuda DH, Stout JR (2017) Beta-alanine supplementation elevates intramuscular carnosine content and attenuates fatigue in men and women similarly but does not change muscle l-histidine content. Nutr Res 48:16–25. CrossRefPubMedGoogle Scholar
  34. 34.
    Varanoske AN, Hoffman JR, Church DD, Coker NA, Baker KM, Dodd SJ, Harris RC, Oliveira LP, Dawson VL, Wang R, Fukuda DH, Stout JR (2018) Comparison of sustained-release and rapid-release beta-alanine formulations on changes in skeletal muscle carnosine and histidine content and isometric performance following a muscle-damaging protocol. Amino Acids. CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  • Bryan Saunders
    • 1
    • 2
    Email author
  • Mariana Franchi
    • 1
  • Luana Farias de Oliveira
    • 1
  • Vinicius da Eira Silva
    • 1
  • Rafael Pires da Silva
    • 1
  • Vitor de Salles Painelli
    • 1
  • Luiz Augusto Riani Costa
    • 1
  • Craig Sale
    • 3
  • Roger Charles Harris
    • 4
  • Hamilton Roschel
    • 1
  • Guilherme Giannini Artioli
    • 1
  • Bruno Gualano
    • 1
  1. 1.Applied Physiology and Nutrition Research Group, School of Physical Education and Sport, Rheumatology Division, Faculty of Medicine FMUSPUniversity of São PauloSão PauloBrazil
  2. 2.Institute of Orthopaedics and Traumatology, Faculty of Medicine FMUSPUniversity of São PauloSão PauloBrazil
  3. 3.Musculoskeletal Physiology Research Group, Sport, Health and Performance Enhancement Research CentreNottingham Trent UniversityNottinghamUK
  4. 4.Junipa LtdNewmarketUK

Personalised recommendations